Inflammasome-independent IL-1β mediates autoinflammatory disease in Pstpip2-deficient mice

Suzanne L. Cassel,John R. Janczy,Xinyu Bing,Shruti P. Wilson,Alicia K. Olivier,Jesse E. Otero,Yoichiro Iwakura,Dmitry M. Shayakhmetov,Alexander G. Bassuk,Yousef Abu-Amer,Kim A. Brogden,Trudy L. Burns,Fayyaz S. Sutterwala,Polly J. Ferguson
DOI: https://doi.org/10.1073/pnas.1318685111
IF: 11.1
2014-01-06
Proceedings of the National Academy of Sciences
Abstract:Significance Chronic recurrent multifocal osteomyelitis (CRMO) is a human disorder of the innate immune system that causes bone inflammation that mimics infectious osteomyelitis. There is a spontaneous mutant mouse model of the disease that is caused by homozygous mutations in the gene Pstpip2 . Our studies show that bone inflammation in this model is mediated by the cytokine IL-1β, but that the disease is independent of the nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3 (NLRP3) inflammasome and caspase-1, which is different from most other IL-1–mediated disorders. Further, we implicate neutrophils and neutrophil serine proteases in disease pathogenesis. These data provide a rationale for directly targeting the IL-1 receptor or IL-1β as a therapeutic strategy in CRMO.
multidisciplinary sciences
What problem does this paper attempt to address?